CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 106 filers reported holding CINCOR PHARMA INC in Q4 2022. The put-call ratio across all filers is 2.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,937,646 | $162,054,000 | 31.05% |
| venBio Partners LLC | 1,862,256 | $61,119,000 | 14.14% |
| Sofinnova Investments, Inc. | 6,079,949 | $199,544,000 | 11.61% |
| Omega Fund Management, LLC | 560,985 | $18,412,000 | 6.74% |
| Perceptive Advisors | 3,306,649 | $108,524,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 301,324 | $9,889,000 | 2.38% |
| SEVEN GRAND MANAGERS, LLC | 20,000 | $656,000 | 2.15% |
| BVF INC/IL | 1,312,443 | $43,074,000 | 1.78% |
| GENERAL ATLANTIC, L.P. | 4,209,470 | $138,155,000 | 1.63% |
| Vivo Capital, LLC | 349,237 | $11,462,000 | 1.26% |